Michael Patterson is the CEO of US Cannabis Pharmaceutical Research and Development LLC (US Cannabis), a privately-held developmental consulting firm which was established in 2014 with the mission of moving society forward through legalized cannabis. US Cannabis develops the legal cannabis/hemp/cbd markets globally across all platforms (education, cultivation, production, dispensing, research and development, management operations and compliance, and physician services).
US Cannabis currently works with national, state, and local governments, sovereign nations, and public/private companies in all aspects of the cannabis/hemp/CBD industry throughout the United States and Internationally.
Mr. Patterson is President and Executive board member of MGMC-Pharma Group, an international medical cannabis pharmaceutical corporation with EU-GMP cannabis cultivation, production, and export/distribution licenses in 6 East African Countries (Lesotho, Tanzania, Malawi, Democratic Republic of Congo, Zimbabwe, Uganda) and offices in Australia, Italy, and the United States. MGMC Global | The African Medical Cannabis Company | Maseru (mgmc-group.com)
Michael is an internationally recognized speaker, subject matter expert in the global cannabis/hemp/cbd industry, and published author. Michael is a member of the Scientific Advisory Board for Akers Bioscience, a NASDAQ listed biotechnology company, International Cannabis/Hemp/CBD SME for Gerson Lehrman Group (GLG)- an International Investment Consulting Group, Advisory Board member for Integrated Compliance Solutions (icslv.com), and Editorial Board Member for AJEM-American Journal of Endocannabinoid Medicine (the world’s first peer-reviewed printed scientific journal dedicated to the study of endocannabinoid science and medicine) (ajendomed.com)
Mr. Patterson is also a board member for the Medical Cannabis Society, Tourette’s Syndrome Awareness Foundation, Cannabis/Hemp/CBD industry writer for Florida MD Magazine, Orlando Medical News, licensed Occupational Therapist and Nursing Home Administrator in 4 states (NJ, NC, VA, FL), and podcast host for “The Cannabis Report with Michael Patterson”
Ann Barnes began her career acting as corporate counsel for several private and publicly listed companies including Manulife Financial, TSN, Cott Corporation, Alliance Atlantis Communications Inc. and acted as General Counsel for Insight Sports Ltd.
Since leaving her legal career, she founded and operated numerous companies in emerging industries. She began North America’s first chia company and owned and operated one of North America’s first hemp and superfood companies. She has published two best selling health and wellness cookbooks. Ann has a popular Tedx Talk that has been watched over 750K times and translated into both American sign language and Arabic.
Ann is the original founder, investor, and Chairman of the world’s first legally licensed cannabis producing company: Peace Naturals Project Inc. Peace Naturals was subsequently purchased by Cronos Group Inc. and later a majority of shares bought by Altira (Marlborough).
Ann is an active director of Red Light Holland Corp, a legal producer and distributor of psilocybin truffles within the Netherlands. Ann is also the Director and Chair of the Special Committee for InstadosePharma Corp., the world’s largest cannabis processor. She is also an advisor to Oasis Adaptogens Inc. a functional mushrooms and adaptogen company that produces consumer-packaged food and plant-based supplements.
Ann is currently the Founder and CEO of Edica Group Inc. (cob. as Edica Naturals), a natural and plant‑based supplement and topical beauty product company.
With 30+ years of experience, founder, visionary, and serial entrepreneur Christina Michael has spent her career committed to collaborating and co-creating purpose driven business. In 2016 Christina began her journey dedicating her energy and experience as a holistic thought leader in the cannabis industry working with notable companies and brands in North America and beyond. Her achievements continue to ground Christina, empowering her to be a catalyst with her heart forward and fierce determination to lead with integrity, patience, empathy, and compassion. From starting her intentional trajectory in the cannabis space supporting business’, opening her own regulated cannabis retail store, founding The Entourage Co. and Cannabis for Harm Reduction non-profit Christina continues to honour and fulfill a personal promise aligned with her professional pursuits, including a recent strategic partnership with Diplomat Consulting working in collaboration further support and advance emerging regulated industries.
Vicki Hilborn is the Engineering Program Coordinator for the Ontario Ministry of Agriculture, Food and Rural Affairs. She received her Bachelors of Applied Science at the University of Waterloo and her Masters of Applied Science at the University of Guelph. She works with the agricultural industry that are dealing with nuisance concerns such as odours and helps parties navigate the Farming and Food Production Protection Act.
In 2010, Terry Roycroft founded MCRCI, the first Canadian private organization with licensed physicians to educate and sign in support of qualified patients looking for legal access and guidance for medicinal cannabis. MCRCI set the standard as the leading pioneers of the cannabis clinic model, within Canada with a team of doctors who specialize in prescribing Cannabis.
As an in demand speaker, Mr. Roycroft travelled internationally educating and bringing awareness around cannabis to medical professionals as well as the general public.
Mr. Roycroft continues to expand his network and database within the industry, locally and internationally, by working with production sites, pharmacists, medical laboratories, doctors, and patients. Recently, Terry founded AltMed, an alternative medicine center, and the psychedelic resource center, MMRC. Terry aims to utilize his network to expand the psychedelic industry in the same way he did for Cannabis.
Dr. Florina Truica is the co-founder and Chief Technology Officer of Cold Plasma Group, Inc. She is a plasma scientist and engineer with two decades of research experience in both academic and commercial R&D, and a passion for creating eco-friendly technology solutions. She has a MSc in Applied Sciences from a Strasbourg Polytechnic University in France, and a PhD in Engineering Physics from École Polytechnique of Montréal in Canada.
Dr. Truica stared her career as an academic researcher, but later switched to commercial R&D working for the Global Research Centre of a multi-national company, Novelis Inc., in Kingston, Ontario. In 2014, she started working for an advanced materials start-up in Kingston, Alcereco / Grafoid Inc., as their Senior Scientist, and later as Director of Technology. Over the years, she has developed several eco-friendly chemical processes as platform technologies for advanced manufacturing, which she has helped evolve from an idea to large-scale commercial implementation. In 2019, she co-founded Cold Plasma Group to bring to market an innovative plasma sterilization technology, and to create automated plasma sterilization machines for the cannabis sector.
She is the author or co-author of several patents and patent applications, and of 45 papers published in peer-reviewed journals and conference proceedings. She has received conference awards and was invited to speak at many international conferences.
Carolyn Burek has a Master’s degree in Biochemistry who has worked in various fields, including biofuels, Academia, and more recently, over four years in the cannabis industry. She is the owner and founder of Metta Research & Design, LLC where she plays a key role in helping clients with the initial design of the facility, equipment procurement, regulatory compliance, standard operating procedures (SOPs), team leadership, and product development. She has worked in over 15 states and Canada and, more recently, has worked heavily in the field of product research and development. She has been an active member of the American Chemical Society (ACS) for the past three years, under the Chemical Health and Safety Division and Cannabis Chemistry subdivision.
Dr. Pamela Kryskow is a medical doctor with a strong interest in psychedelic medicine, mental health and chronic pain.
Founding board members of the Canadian Psychedelic Association. She is part of an expert team working to give Canadians access to psilocybin at end of life.
Dr Kryskow is actively involved in research related to psilocybin, MDMA, ketamine, mental wellness and neurogenesis.
Co-investigator on the largest microdosing study Microdose.me which is ongoing with 14 000+ enrolled participants.
A Clinical Instructor at University of British Columbia and Adjunct Professor at Vancouver Island University.
The medical lead on the Roots To Thrive Ketamine Assisted Therapy program that treats health care providers with PTSD, depression, anxiety, and addiction.
In real life she loves foraging in the forest, ocean kayaking, growing kale and daydreaming in the hammock.
Dr. Bennett was inspired to found Prescott by a desire to share his expertise in cannabinoid research, processing, and product development. A leading expert in the world of cannabis science, Dr. Bennett is a molecular biologist with a Ph.D. in Molecular Medicine from the University of South Florida College of Medicine and a BS in Biochemistry from Eckerd College. His background in neurodegenerative disease, opiate receptors, and melanoma made him passionate about cannabis’ potential to provide relief. He holds two patents and four provisional patents and has published a series of peer-reviewed papers about cannabis innovation and medical uses.
John MacKay, Ph.D. is known for his insightful analogies that bring complex chemistry to everyday activities that we do every day. From making coffee and tea to cleaning our clothes to counting colored candies and rescuing dogs from neighbors with walking sidewalks. Without trivializing the important science or making the easy facts seem impossible to learn, everyone leaves his classes to make scientific and business decisions.
John A. MacKay earned a B.A. in Chemistry from St. Lawrence University (SLU) and a Ph.D. from the University of Vermont (UVM) in Synthetic Inorganic Chemistry. After positions teaching at Davidson College, Lyndon State College, and University of Vermont (UVM), John joined Waters Corporation in 1983.
Dr. MacKay founded Synergistic Technologies Associates, LLC, which has helped many major brands optimize their extrication processes operations based on Six Sigma principles.
With the expertise and desire to spread the science throughout the industry, John has taken on roles as a contributing journalist and science editor for Terpenes and Testing Magazine and was the editor of the first issues of Extraction Magazine and now is contributing journalist and scientific advisor. He has also been appointed the Educator Assistant Professor on the Volunteer Pathway, Department of Pharmacology at the Robert Larner, MD College of Medicines.
Recent Comments